Wezel Pharma SRL

2.0 FTE

Company number (CBE) 0754.807.775 · VAT BE0754807775

2400 Mol

active in Retail sale of pharmaceutical products (NACE 47730)

operating since 24 Sep 2020 (≈ 6 yrs)

Ask Idonis

＋ Add to a list Export to Excel Pro

Public Public page: latest year only. The score, history and details open with a free account. Create a free account

Idonis solidity score

EDCBA

The score of Wezel Pharma shows with a free account.

See the score

Profile

SRL Micro · 2.0 FTE since 2020

Components

Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register

Position in its sectorvs peers
Supplier creditat 30 d
Borrowing capacityborrowable
Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result52,338 €

Equity309,290 €

Cash162,027 €

EBITDA89,554 €

Total assets520,638 €

Headcount (avg FTE)2.0

Solvency59.4%

The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity +51 % Total assets +8 % Headcount (avg FTE) -17 %

Accounts of the company itself (not consolidated).

The full file covers 5 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Wezel Pharma's annual accounts

	2025	2024	2023	2022	2021
Net result	52,338 €
Equity	309,290 €
Cash	162,027 €
EBITDA	89,554 €
Total assets	520,638 €

See all 5 years Export to Excel Pro

Filed annual accounts

Year ended 31 Dec 2025filed on 02 Jul 2026
Year ended 31 Dec 2024filed on 01 Jul 2025
Year ended 31 Dec 2023filed on 01 Jul 2024
Year ended 31 Dec 2022filed on 04 Jul 2023
Year ended 31 Dec 2021filed on 03 Jul 2022

Wezel Pharma's financial analysis

Open the full analysis

Management and control of Wezel Pharma

1 active director(s) in the register.

Wezel Pharma's shareholders and holdings →

See the directors and their mandates

Wezel Pharma's publications in the Belgian Gazette

28 Sep 2020Incorporation

Read the publications in detail

Company number, VAT number and registered office

Company number (CBE): 0754.807.775
VAT number: BE0754807775
Peppol: Registered · 0208:0754807775 · as of 09 Nov 2026
Legal form: SRL
Incorporated: 24 Sep 2020
Registered office: 2400 Mol
Size: Micro · 2.0 FTE
Latest accounts: 2025 · filed on 02 Jul 2026
Activity: Retail sale of pharmaceutical products (NACE 47730)

Wezel Pharma (SRL) has been based in Mol since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 52,338 € and equity of 309,290 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 59.4%, above the median of its sector (44.2%).

Companies similar to Wezel Pharma

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Wezel Pharma

What is the revenue of Wezel Pharma?

Wezel Pharma files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Wezel Pharma?

In Belgium, the VAT number is the company number prefixed with BE: BE0754807775 for Wezel Pharma, if the company is VAT-registered. Its company number (CBE) is 0754.807.775.

Where is the registered office of Wezel Pharma?

According to the CBE register, the registered office of Wezel Pharma is in 2400 Mol.

What is the equity of Wezel Pharma?

At the close of the 2025 financial year, the equity of Wezel Pharma amounts to 309,290 €, a solvency of 59.4% of total assets.

How many people work at Wezel Pharma?

2.0 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Wezel Pharma?

The register lists 1 active mandates at Wezel Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Wezel Pharma

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →

Free account in 30 seconds, by email. No bank card.

Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 08 Aug 2026

	Free	Pro	Enterprise
Ask
Analyses per month	≈ 6	≈ 160	≈ 100 per user, pooled
Credit packs (no expiry)	✓	✓	✓
Unit of account	Your account is debited in credits: one analysis ≈ 25 credits, a pack of 1 000 credits ≈ 40 analyses. The exact balance is in your account, the cost of each answer under it.
The company file
Search by name, CBE number or address	✓	✓	✓
Identity, activity, legal status, published mandates	✓	✓	✓
Idonis Score explained (formula and values)	✓	✓	✓
Annual accounts	last 2 financial years	every filed year	every filed year
Ratios	5 basic	all, with provenance	all, with provenance
Indicative supplier credit and borrowing capacity	—	✓	✓
Estimates (revenue, margins, cash flow)	—	✓	✓
Sector positioning on the company file	—	✓	✓
Indicative valuation (range)	—	✓	✓
Deeds published in the Belgian Gazette	last 12 months	full published history	full published history
Follow
Company lists	1 list of 5	multiple lists	multiple · shared
Dashboard signals (filings, Gazette, score)	✓	✓	✓
E-mail alerts	—	✓	✓
Import of a list of company numbers	—	✓	✓
Understand
Explorer: filters, map	50 results	200 per page	200 per page
Sector pages (medians, comparison)	✓	✓	✓
Excel export (auditable formulas)	—	✓	✓
Network
Directors, mandates and people	—	✓	✓
Ownership graph	1 hop	multi-hop, as of a date	multi-hop, as of a date
Team
Users, admin console, usage per person	—	—	✓
Pooled credits, single invoice	—	—	✓
Shared lists	—	—	✓
Integration
API	—	—	optional
Idonis inside your own AI (MCP)	—	—	optional